⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VIVS News
VivoSim Labs, Inc. Common Stock
VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs
globenewswire.com
VIVS
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
globenewswire.com
VIVS
Form 8-K
sec.gov
VIVS
Form 8-K
sec.gov
VIVS
VivoSim Provides Financial and Listing Compliance Update
globenewswire.com
VIVS
VivoSim Provides Financial and Listing Compliance Update
globenewswire.com
VIVS
Form 8-K
sec.gov
VIVS
Form 8-K
sec.gov
VIVS
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
globenewswire.com
VIVS
Form 8-K
sec.gov
VIVS